For example, mutations in the active sites of isocitrate dehydrogenase 1 (IDH1) and 2 (IDH2), which are reported at frequencies of 6–16% and 8–19%, respectively, are significant in AML [25,48]. The gene discussed is IDH1; the disease is acute myeloid leukemia.